Preclinical research has demonstrated that GLP-1 receptor activation may confer neuroprotective effects through multiple mechanisms
The Meds Changing the Game: GLP-1s Semaglutide (Wegovy) and tirzepatide (Zepbound) are FDAapproved injectables that curb appetite, improve insulin sensitivity, and support sustainable weight loss
Predicting response to fluoxetine in geriatric patients with major depression J Clin Psychopharmacol 1995
"A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults"
Heruye, S.H., Nkenyi, L.N.M., Singh, N.U., Yalzadeh, D., Ngele, K.K., Njie-Mbye, Y., Ohia, S.E., and Opere, C.A., Current Trends in the Pharmacotherapy of Cataracts
People who quit taking the popular GLP-1 drugs might actually be jeopardizing their heart health